Aim: To examine the prospective associations between aspects of a woman's reproductive history and incident diabetes.
| INTRODUCTION
Both the incidence and prevalence of type 2 diabetes (referred to hereafter as diabetes) have increased considerably in recent decades, with current estimates indicating that there are >400 million affected individuals worldwide. 1 Overall, similar numbers of women and men have diabetes, but age-adjusted rates tend to be greater for men than women. 1 Diabetes confers significant health risks, in particular for vascular diseases, where the effect of diabetes appears to be more catastrophic in women than in men. [2] [3] [4] [5] Although the ongoing epidemic of overweight and obesity has fuelled much of the observed increase in diabetes rates globally, there has been growing attention paid to a possible aetiological role for female-specific markers of reproductive health, such as age at menarche, parity and age at menopause, in the development of diabetes. [6] [7] [8] [9] [10] Notable trends in the prevalence of female-specific risk factors such as an increase in the rate of gestational diabetes (itself, a major risk factor for diabetes) observed in populations, 11 and a decline in the mean age of menarche 12 (in part attributable to the increase in childhood obesity) have added to the speculation that they may play a role in the diabetes pandemic.
The question of whether age at menarche (which has been declining in high-income countries) is inversely associated with subsequent increased risk of diabetes has received much attention in recent years 13, 14 ; however, there is a lack of consistency in study findings, 15, 16 possibly as a result of differences in study designs and in background rates of obesity and diabetes in the populations studied.
Quantification of any causal relationship is also hampered by the strong relationship that exists between excess body weight and both early menarche and diabetes. 8, 15, 17 In the present study, we report on the associations between several female reproductive markers and subsequent incidence of diabetes. We also examine if the associations are explained by excess body size in midlife.
2 | METHODS
| Ethics
Participants were recruited according to the institutional review board protocols approved at each of the research centres, and all study participants provided informed written consent. The details of the study ethics are described elsewhere. only studies that had information on selected reproductive characteristics and incident diabetes were included (Table S1 ). The numbers of women and exclusion criteria are presented in Figure 1 . Women's average age at first (or baseline) survey ranged from 45 to 60 years in most studies except for two British birth cohorts for which data from surveys at ages 47 (MRC National Survey of Health and Development) and 50 years (National Child Development Study) were considered as baseline for the present study.
| Measurement of markers of reproductive history
Reproductive factors of interest were age at menarche, age at first birth, number of children (parity), menopausal status/timing, and hormone therapy at baseline. Age at menarche was determined by recall in all studies except for the two British birth cohort stud- and pre-/peri-menopause (menstrual periods in the last 12 months).
Use of menopausal hormone therapy (eg, oestrogen) was categorized as never, past and current users.
| Body mass index and covariates
Body mass index (BMI), defined as weight in kilograms divided by height in metres squared, was self-reported or measured at study baseline, and was categorized as "underweight" (<18.5 kg/m 2 ), "normal weight" (18.5-24.9 kg/m 2 ), "overweight" (25-29.9 kg/m 2 ), and "obese" (≥30 kg/m 2 ) according to the World Health Organization classification. 22 In the multivariable analysis, the following covariates were included: women's year of birth (before 1940, 1940-1949, 1950-1959 and 1960 or after), age at baseline (<40, 40-49, 50-59, 60-69 and ≥ 70 years), years of education (≤10, 11-12 and > 12 years), and smoking status (current, past and never smoker). 
| Case ascertainment

| Statistical analyses
Generalized linear mixed models with binomial distribution and logarithm link 25 were used to analyse the binary outcome of incident dia- 
| Sensitivity analysis
To assess whether there was between-study heterogeneity in the associations and if any single study had undue influence on the overall association, we performed study-specific analyses and tested the heterogeneity in the study level estimates using random-effects metaanalysis.
Further, we carried out a sensitivity analysis that restricted the study sample to only those women with at least 5 years of follow-up (n = 74 885). This was to allow sufficient time for the development of diabetes after hysterectomy/oophorectomy and to minimize the effect of unmeasured confounding factors (ie, a pre-existing condition that both required a woman to have a hysterectomy/oophorectomy and is related to increased risk of diabetes).
3 | RESULTS
| Study characteristics
A total of 126 721 women with complete history available regarding reproductive exposures and relevant covariates comprised the study sample for this analysis ( Figure 1 ). Data were based on eight studies from four predominantly white populations: Australia, Denmark, Sweden and the UK. The study name, country of origin and the number of observations used for each study are provided in Table S1 . Most women (72%) in these populations were born between 1940 and 1959, with only 4% born after 1960. The women's mean (SD) age at baseline survey was 48.6 (9.7) years and at last follow-up it was 56.1
Figure S1 is a histogram showing the distribution of age at menarche in the study population. The mean (median; range) age at menarche was 13.1 (13; 8-20) years, with 15% of women reporting menarche at ≤11 years. Three-quarters of women had ≥2 children, and a similar proportion delivered their first child before the age of 30 years. Just over half (50.2%) of the participants were pre-or perimenopausal at baseline, 2.5% had experienced early menopause (natural menopause before the age of 45 years), and 14% reported having had a hysterectomy or oophorectomy. Age of natural menopause was unknown for~14% of women taking menopausal hormone therapy.
Details of the distribution of reproductive factors in the different studies are provided in Table S2 .
Over a median follow-up of 9 years, 4073 new cases of diabetes were ascertained. The crude incidence of diabetes was 4.3 per 1000
person-years, and the age-adjusted incidence rate was 4.6 per 1000
person-years (ranging from 2.3 to 7.5 per 1000 person-years across the eight cohorts). The distribution of incident cases of diabetes according to age, sociodemographic indices, physiological and reproductive characteristics at study baseline are shown in Table 1 . There were significant differences in the distribution of all of the aforementioned covariates between women with and without incident diabetes.
| Age at menarche and incident diabetes
The association between age at menarche and incident diabetes was non-linear: there was evidence to suggest that only menarche at ≤11 years was associated with increased risk of diabetes compared with those women who were aged 13 years at onset of menarche ( Table 2 ).
The test for interaction indicated potential effect modification by BMI (P for interaction = .06): there was no association among women with a BMI <25 kg/m 2 but a non-linear relation in women with a BMI ≥25 kg/m 2 . In women with a BMI ≥25 kg/m 2 , those who were aged ≤10 years at menarche were at a 33% greater risk of diabetes (RR 1.33, 95% CI 1.13-1.55) compared with women who were aged 13 years at menarche (Table 3 ).
| Age at first birth, parity and incident diabetes
There was a non-linear relationship between age at first birth with incident diabetes in the minimally adjusted model ( Table 2 ) that was ameliorated after adjustment for reproductive factors (Model 2) and midlife BMI (Model 3). The association between parity and incident diabetes was U-shaped and remained after adjustment for other Table 2 ).
| Menopausal status baseline, use of hormone replacement therapy and incident diabetes
Compared with women who were pre-/peri-menopausal, there was an indication that women who reached menopause before the age of 40 years had an elevated but not statistically significant risk of incident diabetes (RR 1.27, 95% CI 0.91-1.76; Table 2 ). Women who reported having had a hysterectomy/oophorectomy at baseline had a 17% increased risk of diabetes (RR 1.17, 95% CI 1.07-1.29) compared with pre-/peri-menopausal women after adjustment for other reproductive factors and midlife BMI. Findings from the sensitivity analysis, which restricted the study sample to only those women with at least 5 years of follow-up, were similar to the main results (Table S3) . Table 3 ).
There was no evidence of an association between hormone therapy use (past or current user vs never) and incident diabetes ( Table 2 ).
| Study-specific results
The random-effects meta-analysis showed the study-specific estimates to be broadly consistent for the following significant associations between markers of reproductive history and incident diabetes:
age at menarche ≤11 years vs 13 years (I 2 = 18.6%, P = .28); having ≥4 vs 2 children (I 2 = 0.9%; P = .42); and hysterectomy/oophorectomy vs pre-/peri-menopause (I 2 = 0.0%, P = .58; Figure S2 ). There was some evidence of between-study heterogeneity for the association between nulliparity and risk of diabetes that was contingent on the findings from two studies (I 2 = 70.5%, P = .001). Exclusion of these studies attenuated the magnitude of the between-study heterogeneity (I 2 = 54.2%, P = .05). The study-specific estimates were consistent but attenuated, after adjusting for midlife BMI ( Figure S3 ).
| DISCUSSION
Findings from this collaboration of population-based cohort studies of women's health add to the accruing evidence that characteristics of a woman's reproductive history may be associated with incident diabetes in later life. Consistent with previous studies 13, 14, 26, 27 early menarche (≤11 years) was associated with a small increase in risk of diabetes compared with menarche at 13 years; however, our findings indicate that the effect is only apparent among women with a midlife a Mean and median age at menopause were only presented among women who had reached menopause at baseline (n = 27 420).
BMI in the overweight or obese range. There are several ways to interpret this finding; it may indicate that remaining relatively lean throughout life effectively mitigates any excess risk conferred by early age at menarche. Alternatively, it may reflect a cumulative exposure to excess body weight beginning in early life; that is, overweight women in adult life were also overweight as children resulting in both early age at menarche and increased risk of diabetes in adult life.
Most studies that have examined the relationship between age at menarche and risk of subsequent diabetes, in the absence of a measure of childhood weight, have used adult BMI as a proxy measure, arguing that overweight and obesity tend to track throughout life (ie, children who are overweight are significantly more likely to remain overweight throughout adulthood). 8, 26 This may be the case for contemporary birth cohorts, but the studies included in the present collaboration included women who were born decades before the obesity epidemic in children. Hence, one would expect relatively few women to have been overweight or obese as children.
The two largest studies to date that have reported on the association between age at menarche and incident diabetes have shown conflicting results. In the EPIC-Interact study, 14 the inverse association between age at menarche and the risk of diabetes persisted after adjustment for BMI. In contrast, in the Women's Health
Initiative, 27 a large study of hormone replacement therapy in postmenopausal women, the inverse association between age at menarche and risk of diabetes was attenuated once adjustment was made for BMI in adult life (as we also found). The discrepancy between these two large studies may be a birth cohort effect or may be attributable to the use of different categories for menarche age, and Abbreviations: BMI, body mass index; CI, confidence interval; RR, relative risk. Model 1: adjusted for women's year of birth, age at baseline, education and smoking status at baseline. Model 2: adjusted for covariates in model 1 plus age at menarche, number of children, age at first birth, menopausal status/timing and hormone therapy at baseline. Model 3: adjusted for covariates in model 2 plus baseline BMI (under/normal weight, overweight and obese).
it would be of interest to know whether stratification by BMI in these studies would yield findings similar to ours.
In InterLACE, parity was non-linearly associated with risk of diabetes such that, compared with women with two children, both nulliparous women and women with ≥4 children were at increased risk of diabetes. The relationship, which was broadly consistent across the included studies, was independent of other reproductive risk factors and midlife BMI. These findings are consistent with other populationbased cohort studies where nulliparity or having ≥4 children were independently associated with greater risk of diabetes in later life. 28, 29 Our findings contrast slightly with those of a recent meta-analysis of published results from seven studies. In that overview, although the association between parity and incident diabetes was non-linear, the authors aggregated the heterogeneous study estimates and presented a dose-response relationship, such that for every live birth increase in parity the risk of diabetes increased by 6%. 30 Although beyond the scope of these data, possible mechanistic explanations for this association include cumulative exposure to repeat periods of increased insulin resistance and pancreatic β-cell proliferation during pregnancy and subsequent β-cell dysfunction. 30 Women who had had either a hysterectomy or oophorectomy had a modest increased risk of diabetes that was robust to adjustment for potential confounders. These findings are consistent with those from both animal and epidemiological studies, which indicate that oophorectomy and surgical menopause is associated with increased insulin resistance, metabolic disturbances and incident diabetes. 31 In particular, two large prospective studies have shown an increased risk of incident diabetes following hysterectomy and/or oophorectomy in post-menopausal women. 32, 33 There was some evidence from our data that premature menopause (menopause by the age of 40 years)
is related to risk of incident diabetes. The non-significant result may be attributable to lack of statistical power. Previous studies have suggested that premature and early natural menopause are associated with subsequent risk of diabetes. 34 Most recently, data from the Rotterdam Study showed a 3-fold increased risk of diabetes for women who experienced premature menopause compared with those who experienced menopause after the age of 55 years, although the number of incident cases of diabetes in both groups (n = 29) was much smaller than in the present study. Previous authors have speculated on possible genetic mechanisms linking early age at menopause (possibly a proxy for premature ageing and DNA damage) with risk of incident diabetes and other chronic, age-related conditions. 34 It remains to be determined by future studies whether early age at menopause predicts future health outcomes.
A strength of the present study is the large pool of individuallevel data that span several geographic regions. InterLACE harmonized variables using common definitions and provided sufficient heterogeneity and statistical power to examine the subgroups. The present study also has some limitations that warrant brief discussion. Only the two birth cohorts 20, 21 had a measure of childhood weight status, which meant that we were unable to adjust for its potential confounding effect in the analysis; however, given that~95% of the participants were born before 1960 (several decades before the childhood obesity epidemic commenced), we believe it is unlikely that a significant proportion of these women was overweight in childhood and therefore we consider the potential confounding effect to be minimal.
The National Survey of Health and Development study that did have data on childhood weight supports this hypothesis; at age 11 years, <2% of the women were overweight or obese, and this increased to 7% at age 15 years (data not shown). Age at menarche was predominantly based on recall; the error that this would have introduced is likely to have been non-differentially distributed across the cohorts and would have biased any associations towards the null. Diagnosis of diabetes was also largely by self-report, which raises the possibility of misclassification of outcome; however, previous longitudinal cohort studies have indicated that self-reported diabetes is >90% reliable for diabetes status over time. 35 Moreover, any misclassification of diabetes status is likely to be non-differentially distributed across the categories of age at menarche. Approximately 21% of observations were dropped in our complete case analysis because of missing data on covariates. When the missing data were imputed using multiple imputation and analysed (data not shown), we did not find an overall difference in our estimates except for early age at menarche and early menopause, which slightly improved, suggesting slight underestimation of these factors.
In summary, early age of menarche may be a risk factor for incident diabetes but it remains to be determined whether the effect is purely driven by early overweight and obesity tracking into adult life.
Parity and a history of hysterectomy or oophorectomy appear to be related to incident diabetes, although the effect sizes were modest and thus, the associations could still be attributable to residual confounding. By contrast, there was no clear evidence that use of hormone replacement therapy, age at natural menopause and age at which a woman has her first child are independently associated with risk of diabetes. Whether the relationships that we, and others, have observed between markers of reproductive health and incident diabetes are truly causal, and predictive of diabetes in later life, remains to be determined and is subject to investigation by future studies.
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